デフォルト表紙
市場調査レポート
商品コード
925385

世界の細胞増殖市場:成長、動向、予測(2020年~2025年)

Cell Expansion Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
世界の細胞増殖市場:成長、動向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

慢性疾患の発生率の増加、および細胞ベース治療法の研究開発への注目の高まりなどが、細胞増殖市場を牽引する主要な要因であると予測されます。

当レポートでは、世界の細胞増殖市場を調査し、市場の概要、製品・用途・セルタイプ・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 慢性疾患の発生率の増加
    • 政府の投資の増加
    • 研究開発への焦点の増加
  • 市場抑制要因
    • 細胞生物学の研究に対する倫理的懸念
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場セグメンテーション

  • 製品別
    • 消耗品
    • 試薬、培地、および血清
    • 機器
  • セルタイプ別
    • ヒト細胞
    • 動物細胞
  • 用途別
    • 再生医療・幹細胞研究
    • 癌・細胞ベースの研究
    • その他
  • エンドユーザー別
    • バイオ医薬品・バイオテクノロジー企業
    • 研究機関
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • Becton, Dickinson and Company
    • Terumo BCT
    • Merck KGaA
    • Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
    • Miltenyi Biotec
    • Lonza Group LTD.
    • Stemcell Technologies, Inc.
    • GE Healthcare
    • Takara Bio Inc.

第7章 市場機会および将来動向

目次
Product Code: 67973

The cell expansion market will show rapid growth due to the increasing incidence of chronic diseases, government investments for cell-based research and increasing focus on R&D for cell-based therapies.

The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the cell expansion market. Cardiovascular disease (CVD) is the leading cause of mortality worldwide. According to the WHO, an estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths.

There is an increase in the prevalence of cancer patients that results in a large patient pool, which creates an opportunity for the manufacturers to tap and capitalize on the market. Hence there is an increase in the cases of chronic diseases that are expected to drive the overall market. Furthermore, technological advances in cell expansion devices and growth in government investments regarding healthcare issues are the factors propelling the market.

Key Market Trends

Consumables is Expected to be the Largest Growing Segment in the Cell Expansion Market

The consumables segment has been accounted for the largest share of the market and this is mainly due to the high demand during the production of regenerative medicine and rising research activities on stem cells in the biopharmaceutical companies. There is also a constant requirement for new reagents among end-users that helps in market growth. Furthermore, the rising awareness regarding advanced treatment therapies such as personalized medicine is also another driving factor for this segment.

North America is Found Leading the Cell Expansion Market

The increasing incidences of chronic and cell-based diseases and rising geriatric population are the key factors driving the overall market in this region. The rising investment made by the companies as well as the government for cell expansion research is also a factor driving the market in this region.

The Asia Pacific is poised to grow owing to rapidly expanding biotechnology and biopharmaceutical industries, increasing government investments for cancer and stem cell research and rising focus of prominent players on the emerging markets.

Competitive Landscape

There has been a presence of a considerable number of companies that are mainly focusing on agreements and expansions to strengthen its business operations. There are various established business players that are adopting numerous organic and inorganic growth strategies to increase their market share. New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Chronic Diseases
    • 4.2.2 Government Investments for Cell-Based Research
    • 4.2.3 Increasing Focus on R&D for Cell-Based Therapies
  • 4.3 Market Restraints
    • 4.3.1 Ethical Concerns Regarding Research in Cell Biology
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Consumables
    • 5.1.2 Reagents, Media, & Serum
    • 5.1.3 Disposables
    • 5.1.4 Instruments
      • 5.1.4.1 Cell Expansion Supporting Equipment
      • 5.1.4.2 Bioreactors
      • 5.1.4.3 Automated Cell Expansion Systems
  • 5.2 By Cell Type
    • 5.2.1 Human Cells
    • 5.2.2 Animal Cells
  • 5.3 By Application
    • 5.3.1 Regenerative Medicine and Stem Cell Research
    • 5.3.2 Cancer and Cell-Based Research
    • 5.3.3 Other Applications
  • 5.4 By End User
    • 5.4.1 Biotechnology & Biopharmaceutical Companies
    • 5.4.2 Research Institutes
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle-East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific, Inc.
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Terumo BCT
    • 6.1.4 Merck KGaA
    • 6.1.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
    • 6.1.6 Miltenyi Biotec
    • 6.1.7 Lonza Group LTD.
    • 6.1.8 Stemcell Technologies, Inc.
    • 6.1.9 GE Healthcare
    • 6.1.10 Takara Bio Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS